236 related articles for article (PubMed ID: 27865192)
1. Effect of targeted therapy on circulating progenitor cells in precapillary pulmonary hypertension.
García-Lucio J; Tura-Ceide O; Del Pozo R; Blanco I; Pizarro S; Ferrer E; Díez M; Coll-Bonfill N; Piccari L; Peinado VI; Barberà JA
Int J Cardiol; 2017 Feb; 228():238-243. PubMed ID: 27865192
[TBL] [Abstract][Full Text] [Related]
2. Distinct patterns of circulating endothelial cells in pulmonary hypertension.
Smadja DM; Mauge L; Sanchez O; Silvestre JS; Guerin C; Godier A; Henno P; Gaussem P; Israël-Biet D
Eur Respir J; 2010 Dec; 36(6):1284-93. PubMed ID: 20413531
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic changes by breathing hypoxic and hyperoxic gas mixtures in pulmonary arterial and chronic thromboembolic pulmonary hypertension.
Groth A; Saxer S; Bader PR; Lichtblau M; Furian M; Schneider SR; Schwarz EI; Bloch KE; Ulrich S
Int J Cardiol; 2018 Nov; 270():262-267. PubMed ID: 29891241
[TBL] [Abstract][Full Text] [Related]
4. Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.
Godinas L; Sattler C; Lau EM; Jaïs X; Taniguchi Y; Jevnikar M; Weatherald J; Sitbon O; Savale L; Montani D; Simonneau G; Humbert M; Laveneziana P; Garcia G
J Heart Lung Transplant; 2017 Nov; 36(11):1234-1242. PubMed ID: 28666570
[TBL] [Abstract][Full Text] [Related]
5. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.
Yaoita N; Shirakawa R; Fukumoto Y; Sugimura K; Miyata S; Miura Y; Nochioka K; Miura M; Tatebe S; Aoki T; Yamamoto S; Satoh K; Kimura T; Shimokawa H; Horiuchi H
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2486-94. PubMed ID: 25169936
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.
Khirfan G; Tejwani V; Wang X; Li M; DiDonato J; Dweik RA; Smedira N; Heresi GA
PLoS One; 2018; 13(5):e0197700. PubMed ID: 29813091
[TBL] [Abstract][Full Text] [Related]
7. Protective role of endothelial progenitor cells stimulated by riociguat in chronic thromboembolic pulmonary hypertension.
Yamamoto K; Nishimura R; Kato F; Naito A; Suda R; Sekine A; Jujo T; Shigeta A; Sakao S; Tanabe N; Tatsumi K
Int J Cardiol; 2020 Jan; 299():263-270. PubMed ID: 31337550
[TBL] [Abstract][Full Text] [Related]
8. Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study.
Nakamura H; Kato M; Nakaya T; Kono M; Tanimura S; Sato T; Fujieda Y; Oku K; Ohira H; Bohgaki T; Yasuda S; Tsujino I; Nishimura M; Atsumi T
Medicine (Baltimore); 2017 Oct; 96(43):e8349. PubMed ID: 29069014
[TBL] [Abstract][Full Text] [Related]
9. Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
Bartenstein P; Saxer S; Appenzeller P; Lichtblau M; Schwarz EI; Ulrich S
Respiration; 2018; 96(2):127-137. PubMed ID: 29642071
[TBL] [Abstract][Full Text] [Related]
10. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.
Diller GP; van Eijl S; Okonko DO; Howard LS; Ali O; Thum T; Wort SJ; Bédard E; Gibbs JS; Bauersachs J; Hobbs AJ; Wilkins MR; Gatzoulis MA; Wharton J
Circulation; 2008 Jun; 117(23):3020-30. PubMed ID: 18519847
[TBL] [Abstract][Full Text] [Related]
11. Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.
Charalampopoulos A; Gibbs JS; Davies RJ; Gin-Sing W; Murphy K; Sheares KK; Pepke-Zaba J; Jenkins DP; Howard LS
J Appl Physiol (1985); 2016 Sep; 121(3):623-8. PubMed ID: 27418685
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension.
Bonderman D; Turecek PL; Jakowitsch J; Weltermann A; Adlbrecht C; Schneider B; Kneussl M; Rubin LJ; Kyrle PA; Klepetko W; Maurer G; Lang IM
Thromb Haemost; 2003 Sep; 90(3):372-6. PubMed ID: 12958604
[TBL] [Abstract][Full Text] [Related]
13. Neopterin as a Biomarker in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
Smukowska-Gorynia A; Marcinkowska J; Chmara E; Malaczynska-Rajpold K; Slawek-Szmyt S; Cieslewicz A; Janus M; Araszkiewicz A; Jankiewicz S; Komosa A; Olasinska-Wisniewska A; Tomaszewska I; Mularek-Kubzdela T
Respiration; 2018; 96(3):222-230. PubMed ID: 29909420
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
Akizuki M; Sugimura K; Aoki T; Kakihana T; Tatebe S; Yamamoto S; Sato H; Satoh K; Shimokawa H; Kohzuki M
Respirology; 2020 Apr; 25(4):427-434. PubMed ID: 31261445
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic and inflammatory biomarkers in the differentiation of pulmonary hypertension.
Säleby J; Bouzina H; Lundgren J; Rådegran G
Scand Cardiovasc J; 2017 Oct; 51(5):261-270. PubMed ID: 28776404
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension: an endothelin receptor antagonist improves the peak PETCO2.
Hirashiki A; Adachi S; Nakano Y; Kono Y; Shimazu S; Shimizu S; Morimoto R; Okumura T; Takeshita K; Yamada S; Murohara T; Kondo T
Life Sci; 2014 Nov; 118(2):397-403. PubMed ID: 24641953
[TBL] [Abstract][Full Text] [Related]
17. Mid-term efficacy of beraprost, an oral prostacyclin analog, in the treatment of distal CTEPH: a case control study.
Vizza CD; Badagliacca R; Sciomer S; Poscia R; Battagliese A; Schina M; Agati L; Fedele F
Cardiology; 2006; 106(3):168-73. PubMed ID: 16645271
[TBL] [Abstract][Full Text] [Related]
18. Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties.
Ulrich S; Fischler M; Speich R; Popov V; Maggiorini M
Chest; 2006 Sep; 130(3):841-6. PubMed ID: 16963684
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.
Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
Curr Med Res Opin; 2011 Sep; 27(9):1763-8. PubMed ID: 21793646
[TBL] [Abstract][Full Text] [Related]
20. Red Blood Cells Distribution Width as a Potential Prognostic Biomarker in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
Smukowska-Gorynia A; Tomaszewska I; Malaczynska-Rajpold K; Marcinkowska J; Komosa A; Janus M; Olasinska-Wisniewska A; Slawek S; Araszkiewicz A; Jankiewicz S; Mularek-Kubzdela T
Heart Lung Circ; 2018 Jul; 27(7):842-848. PubMed ID: 29107511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
